Power to Protect your heart failure patients
Guidelines
Guidelines recommend the 4-pillar approach in managing HFrEF. What is a practical approach to implement this?
from Let's Talk! - Dr. James Januzzi
How has the HFpEF guidelines evolved with the advent of SGLT2i trials?
from Let's Talk! - Prof. Andrew Coats
Efficacy
What is the impact of SGLT2i trials in HFpEF?
from Let's Talk! - Prof. Andrew Coats
What is the impact on the treatment landscape from the early benefits seen in the EMPEROR trials?
from Let's Talk! - Prof. Andrew Coats
What do we know about the consistency of the results for empagliflozin across the spectrum of ejection fraction?
from Let's Talk! - Dr. James Januzzi
What is the role of empagliflozin in patients hospitalized for heart failure?
from Let's Talk! - Dr. James Januzzi
Safety
What makes SGLT2i an ideal HF therapy?
from Let's Talk! - Dr. James Januzzi
What are the kidney benefits that empagliflozin can offer to heart failure patients?
from Let's Talk! - Dr. James Januzzi
PC-ASK-100082